Pascal Furet Selected Research

Pascal Furet Research Topics

Disease

29	Neoplasms (Cancer) 01/2022 - 02/2002
5	Leukemia 01/2018 - 02/2002
4	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2018 - 03/2004
4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2018 - 09/2004
2	Neoplasm Metastasis (Metastasis) 01/2017 - 12/2002
2	Breast Neoplasms (Breast Cancer) 03/2012 - 06/2009
1	Liver Neoplasms (Liver Cancer) 12/2019
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019
1	Systemic Mastocytosis 01/2018
1	Philadelphia Chromosome 01/2017
1	Cholangiocarcinoma 01/2017
1	Pulmonary Arterial Hypertension 01/2016
1	Endometriosis 03/2012
1	Vascular Remodeling 09/2010
1	Polycythemia (Erythrocytosis) 07/2010
1	Myeloproliferative Disorders (Myeloproliferative Disorder) 03/2010
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 09/2004
1	Colorectal Neoplasms (Colorectal Cancer) 03/2004
1	Melanoma (Melanoma, Malignant) 12/2002

Drug/Important Bio-Agent (IBA)

9	Pharmaceutical PreparationsIBA 01/2018 - 01/2003
8	Proteins (Proteins, Gene)FDA Link 01/2019 - 10/2002
7	Phosphotransferases (Kinase)IBA 01/2018 - 02/2002
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2016 - 12/2002
4	NVP-CGM097IBA 11/2018 - 05/2015
4	Imatinib Mesylate (Gleevec)FDA Link 08/2011 - 02/2002
3	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 06/2009 - 02/2002
2	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2022 - 05/2014
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 05/2015
2	LigandsIBA 01/2019 - 09/2010
2	midostaurinIBA 01/2018 - 12/2008
2	Oncogene Proteins (Oncogene Protein)IBA 01/2018 - 12/2004
2	Aromatase (CYP19)IBA 03/2012 - 06/2009
2	Estrogen ReceptorsIBA 03/2012 - 06/2009
2	vatalanib (PTK787)IBA 06/2009 - 03/2004
2	Tyrosine Kinase InhibitorsIBA 06/2009 - 03/2004
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 04/2009 - 07/2008
2	Protein Kinases (Protein Kinase)IBA 12/2008 - 02/2002
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 09/2004 - 02/2002
2	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2003 - 02/2002
1	roblitinibIBA 12/2019
1	capmatinibIBA 01/2019
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2019
1	siremadlinIBA 11/2018
1	Investigational DrugsIBA 01/2018
1	Protein Kinase InhibitorsIBA 01/2018
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2017
1	Circulating Tumor DNAIBA 01/2017
1	infigratinibIBA 01/2017
1	asciminibIBA 01/2017
1	Cell-Free Nucleic AcidsIBA 01/2017
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2016
1	Proto-Oncogene Proteins c-mdm2IBA 08/2015
1	AlpelisibIBA 05/2014
1	Tyrosine (L-Tyrosine)FDA Link 08/2011
1	Erythropoietin FDA Link 07/2010
1	Phenylalanine (L-Phenylalanine)FDA Link 07/2010
1	Amino Acids FDA Link 07/2010
1	QuinoxalinesIBA 07/2010
1	Valine (L-Valine)FDA Link 07/2010
1	NVP-BSK805IBA 07/2010
1	Angiogenesis InhibitorsIBA 06/2009
1	Adenosine Triphosphate (ATP)IBA 01/2009
1	PoisonsIBA 01/2009
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 01/2009
1	EnzymesIBA 01/2009
1	NVP-AST487IBA 12/2008
1	Indicators and Reagents (Reagents)IBA 12/2008
1	TOR Serine-Threonine KinasesIBA 07/2008
1	dactolisibIBA 07/2008
1	Bevacizumab (Avastin)FDA Link 03/2004
1	Monoclonal AntibodiesIBA 03/2004
1	Peptides (Polypeptides)IBA 10/2002
1	tyrosine receptor (receptor, tyrosine)IBA 02/2002
1	PKI 166IBA 02/2002
1	ErbB Receptors (EGF Receptor)IBA 02/2002

Therapy/Procedure

12	Therapeutics 01/2021 - 03/2004
1	Drug Therapy (Chemotherapy) 02/2002